Skin Biopsy Market 2019 growing with CAGR of 9.4 % By 2023 | Top Key Players, Share and Global Industry Trends Analysis by MRFR

Skin Biopsy Market 2019 growing with CAGR of 9.4 % By 2023 | Top Key Players, Share and Global Industry Trends Analysis by MRFR

“Skin Biopsy Market”
An expert on premium research reports, Market Research Future has added a report titled “Global Skin Biopsy Market 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

The global skin biopsy market is expected to exhibit a strong 9.4% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The report presents a detailed analysis of the global skin biopsy market by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global skin biopsy market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. Various components of the global skin biopsy market are also studied in the report and projections are made for the growth trajectory of each distinct component. The various segments and sub-segments within the global skin biopsy market are studied in detail in the report. The study also makes a detailed analysis of the major players operating in the global skin biopsy market and provides a detailed look at the various competitive strategies employed by players in the global skin biopsy market. Likely future conditions with respect to the competitive landscape of the market are also explained in detail in the report.

Get Free Sample Copy @  https://www.marketresearchfuture.com/sample_request/4650

The growing prevalence of skin cancer is primarily the major driver for the global skin biopsy market. Biopsy is the best way of confirming cancer, leading to growing use of skin biopsy in cancer diagnostics. According to the World Health Organization (WHO), about 3 million non-melanoma skin cancers, in addition to about 132,000 melanoma skin cancers, occur each year. One in every three cancers diagnosed is projected to be a case of skin cancer. This has raised awareness about skin cancer among the general populace. This has led to a growing demand from the skin biopsy market, as skin biopsy remains the best tool to confirm the presence of skin cancer.

Increasing air and water pollution are also likely to play a part in the growing skin biopsy market. Air pollution is a strong causative agent for skin diseases such as dermatitis and psoriasis, as toxins in the air have a deteriorating effect on skin tissue, rendering them unable to fight off pathogens. This is also likely to remain a key driver for the global skin biopsy market over the forecast period.

Competitive Analysis:

Leading players in the global skin biopsy market include Cardinal Health, Hologic Inc., Gallini Srl, Devicor Medical Products Inc., DTR Medical Ltd., BD, Cook Medical, and Boston Scientific Corporation.

In March 2019, researchers found a way to detect prions indicating the presence of mad cow disease through a skin biopsy. This method offers much faster diagnosis of mad cow disease than conventional methods.

Segmentation:

The global skin biopsy market is segmented on the basis of type, device, indication, end use, and region.

By type, the global skin biopsy market is segmented into shave biopsy, punch biopsy, excisional biopsy, and incisional biopsy.

By device, the global skin biopsy market is segmented into needle-based biopsy guns, biopsy curettes and punches, guidance systems, biopsy forceps, biopsy needles, and others.

On the basis of indication, the global skin biopsy market is segmented into actinic keratosis, dermatitis, psoriasis, skin infection, cancer, and others. The skin infection segment is further sub-segmented into viral infections, deep fungal infections, basal cell carcinoma, squamous cell carcinoma, and melanoma.

By end use, the global skin biopsy market is segmented into hospitals, dermatology clinics, and others.

Regional Analysis:

The Americas region holds the dominant share in the global skin biopsy market, followed by Europe. The growing prevalence of skin conditions in North America and the growing awareness about the same is likely to drive the skin biopsy market in the Americas region over the forecast period. Europe is the second largest regional market for skin biopsy procedures, followed by Asia Pacific. The latter is likely to grow at the fastest pace over the forecast period.

Browse 110 Pages Premium Research Enabled with Detailed Tables and Figures @ https://www.marketresearchfuture.com/reports/skin-biopsy-market-4650

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/skin-biopsy-market-4650